Preferred Label : Nivolumab Regimen;

NCIt synonyms : Opdivo Regimen;

NCIt related terms : Nivolumab monotherapy;

NCIt definition : A regimen consisting of nivolumab that may be used in the treatment of Hodgkin lymphoma (HL), T-cell lymphoma, diffuse large B-cell lymphoma (DLBCL), appendiceal and small bowel adenocarcinoma; chronic lymphocytic leukemia (CLL); small lymphocytic lymphoma (SLL); anal, bladder, hepatobiliary, colorectal, kidney, cervical, endometrial, vulvar, head and neck, including cancer of the nasopharynx, esophageal and esophagogastric junction, small cell lung and non-small cell lung cancers; peritoneal and pleural mesothelioma, cutaneous and uveal melanoma, Merkel cell carcinoma, anaplastic thyroid carcinoma, gestational trophoblastic neoplasia (GTN), and soft tissue sarcoma.;

NCI Metathesaurus CUI : CL969181;

Codes from synonyms : 3192;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3279375/fr/opdivo-nivolumab-/-opdivo-yervoy-nivolumab-ipilimumab
2021
false
false
false
France
French
guidelines for drug use
antineoplastic combined chemotherapy protocols
Nivolumab
Ipilimumab/Nivolumab Regimen
Ipilimumab
Antineoplastic Agents, Immunological
adult
Malignant Pleural Mesothelioma
disease progression
Cancer Progression
infusions, intravenous
Refractory Pleural Malignant Mesothelioma
continuity of patient care
Nivolumab Regimen
nivolumab
ipilimumab
evaluation of the transparency committee
Mesothelioma, Malignant

---
Nous contacter.
31/10/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.